Oral immune globulin
Patent 4477432 Issued on October 16, 1984. Estimated Expiration Date: 
April 5, 2002. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
April 5, 2002. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesEmployment of enteric coated IgA for hypoproteinemia in intestinal infectious diseases Patent #: 4335099 InventorAssigneeApplicationNo. 06/365759 filed on 04/05/1982US Classes:424/165.1, Staphylococcus or Streptococcus (e.g., pneumococcus or Streptococcus pneumoniae, Streptococcus mutans, etc.)424/130.1, IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL424/157.1, Derived from, or present in, food product (e.g., milk, colostrum, whey, eggs, etc.)424/164.1, Binds bacterium or component thereof or substance produced by said bacterium424/169.1, Escherichia424/176.1, Free from infectious agents (e.g., viruses or bacteria removed or inactivated, etc.)514/885IMMUNE RESPONSE AFFECTING DRUGExaminersPrimary: Rosen, SamAttorney, Agent or FirmInternational ClassA61K 39/395 (20060101)AbstractThere is disclosed an oral pharmaceutical composition for therapeutic use comprising a therapeutically effective amount of orally administerable immune globulin in a pharmaceutically acceptable carrier.Other References
| |
